查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378952

药物发现资讯学市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Drug Discovery Informatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球药物发现资讯学市场规模达到30亿美元。展望未来， IMARC Group预计到2028年市场规模将达到56亿美元，2022-2028年复合年增长率（CAGR）为11.0%。

药物发现资讯学是一种用于分析和解释大量生化资料的技术解决方案。这些资料是从临床实验室出于研究目的进行的实验中产生的，并用于产生有关各种药物开发的见解。它涉及大量基于软体和硬体的工具，用于药物发现和开发的测序、目标资料分析、资料可视化、对接、分子建模、资料库保护。因此，它被医疗机构、製药和生物技术组织以及合约研究组织 (CRO) 广泛使用。

全球医疗保健和製药行业的显着成长是创造积极市场前景的关键因素之一。此外，慢性疾病的盛行率不断上升以及对治疗罕见疾病的有效解决方案的需求不断增加也促进了市场的成长。药物发现资讯学被製药组织广泛用于分析新药物实体和处理来自多个来源的生物资讯。此外，各种技术进步，例如创新的基于生理学的药物动力学 (PBPK) 模拟器平台的开发，有助于透过建模和模拟预测药物动力学结果，也是其他生长诱导因素。与此一致，政府和私人医疗机构增加投资开发孤儿药也有助于市场成长。其他因素，包括老年人口的增加，以及生物资讯学领域广泛的研发（R&D）活动，预计将进一步推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球药物发现资讯学市场表现如何，未来几年将如何表现？
  • COVID-19 对全球药物发现资讯学市场有何影响？
  • 主要区域市场有哪些？
  • 基于工作流程的市场区隔是怎样的？
  • 基于功能的市场区隔是什么？
  • 基于模式的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球药物发现资讯学市场的结构如何？谁是关键参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球药物发现资讯学市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依工作流程划分市场

  • 药物发现
    • 市场走向
    • 市场预测
  • 药物开发
    • 市场走向
    • 市场预测

第 7 章：按功能分類的市场

  • 序列分析平台
    • 市场走向
    • 市场预测
  • 分子模拟
    • 市场走向
    • 市场预测
  • 分子对接
    • 市场走向
    • 市场预测
  • 临床试验数据管理
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按模式分類的市场区隔

  • 外包
    • 市场走向
    • 市场预测
  • 内部
    • 市场走向
    • 市场预测

第 9 章：最终用户的市场区隔

  • 製药公司
    • 市场走向
    • 市场预测
  • 生技公司
    • 市场走向
    • 市场预测
  • 合约研究组织 (CRO)
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Accenture PLC
    • Certara
    • Charles River Laboratories Inc.
    • Collaborative Drug Discovery Inc.
    • Eurofins DiscoverX Products
    • Infosys Ltd.
    • International Business Machines Corporation
    • Jubilant Biosys Limited
    • Oracle Corporation
    • PerkinElmer Inc.
    • Selvita
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A3515

Abstract

The global drug discovery informatics market size reached US$ 3.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.6 Billion by 2028, exhibiting a growth rate (CAGR) of 11.0% during 2022-2028.

Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global drug discovery informatics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on workflow, function, mode and end user.

Breakup by Workflow:

Drug Discovery

Drug Development

Breakup by Function:

Sequence Analysis Platforms

Molecular Modelling

Molecular Docking

Clinical Trial Data Management

Others

Breakup by Mode:

Outsourced

In-house

Breakup by End User:

Pharmaceutical Companies

Biotechnology Companies

Contract Research Organization (CROs)

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global drug discovery informatics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug discovery informatics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the workflow?
  • What is the breakup of the market based on the function?
  • What is the breakup of the market based on the mode?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug discovery informatics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Discovery Informatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Workflow

  • 6.1 Drug Discovery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Development
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Function

  • 7.1 Sequence Analysis Platforms
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Molecular Modelling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Docking
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinical Trial Data Management
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Mode

  • 8.1 Outsourced
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In-house
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biotechnology Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organization (CROs)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Accenture PLC
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Certara
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Charles River Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Collaborative Drug Discovery Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Eurofins DiscoverX Products
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Infosys Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 International Business Machines Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Jubilant Biosys Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Oracle Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 PerkinElmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Selvita
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug Discovery Informatics Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Discovery Informatics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Drug Discovery Informatics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Drug Discovery Informatics Market: Breakup by Workflow (in %), 2022
  • Figure 5: Global: Drug Discovery Informatics Market: Breakup by Function (in %), 2022
  • Figure 6: Global: Drug Discovery Informatics Market: Breakup by Mode (in %), 2022
  • Figure 7: Global: Drug Discovery Informatics Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Drug Discovery Informatics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Drug Discovery Informatics (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Drug Discovery Informatics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Drug Discovery Informatics (Drug Development) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Drug Discovery Informatics (Drug Development) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Drug Discovery Informatics (Molecular Modelling) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Drug Discovery Informatics (Molecular Modelling) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Drug Discovery Informatics (Molecular Docking) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Drug Discovery Informatics (Molecular Docking) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Drug Discovery Informatics (Other Functions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Drug Discovery Informatics (Other Functions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Drug Discovery Informatics (Outsourced) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Drug Discovery Informatics (Outsourced) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Drug Discovery Informatics (In-house) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Drug Discovery Informatics (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Drug Discovery Informatics (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Drug Discovery Informatics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Drug Discovery Informatics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Drug Discovery Informatics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: North America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: United States: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: United States: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Canada: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Canada: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Asia-Pacific: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Asia-Pacific: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: China: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: China: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Japan: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Japan: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: India: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: India: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: South Korea: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: South Korea: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Australia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Australia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Indonesia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Indonesia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Europe: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Europe: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Germany: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Germany: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: France: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: France: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: United Kingdom: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: United Kingdom: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Italy: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Italy: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Spain: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Spain: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Russia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Russia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Latin America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Latin America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Brazil: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Brazil: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Mexico: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Mexico: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Middle East and Africa: Drug Discovery Informatics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Middle East and Africa: Drug Discovery Informatics Market: Breakup by Country (in %), 2022
  • Figure 83: Middle East and Africa: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Global: Drug Discovery Informatics Industry: SWOT Analysis
  • Figure 85: Global: Drug Discovery Informatics Industry: Value Chain Analysis
  • Figure 86: Global: Drug Discovery Informatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Discovery Informatics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Drug Discovery Informatics Market Forecast: Breakup by Workflow (in Million US$), 2023-2028
  • Table 3: Global: Drug Discovery Informatics Market Forecast: Breakup by Function (in Million US$), 2023-2028
  • Table 4: Global: Drug Discovery Informatics Market Forecast: Breakup by Mode (in Million US$), 2023-2028
  • Table 5: Global: Drug Discovery Informatics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Drug Discovery Informatics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Drug Discovery Informatics Market: Competitive Structure
  • Table 8: Global: Drug Discovery Informatics Market: Key Players